146 related articles for article (PubMed ID: 2388639)
1. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
Sano M; Stern Y; Marder K; Mayeux R
Mov Disord; 1990; 5(3):230-4. PubMed ID: 2388639
[TBL] [Abstract][Full Text] [Related]
2. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L
Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive function in alcoholics in a double-blind study of piracetam].
Buranji I; Skocilić Z; Kozarić-Kovacić D
Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
[TBL] [Abstract][Full Text] [Related]
4. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
6. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
Mateo D; Giménez-Roldán S
Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
[TBL] [Abstract][Full Text] [Related]
7. Effect of piracetam on cognitive performance in patients undergoing bypass surgery.
Uebelhack R; Vohs K; Zytowski M; Schewe HJ; Koch C; Konertz W
Pharmacopsychiatry; 2003 May; 36(3):89-93. PubMed ID: 12806565
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
Oosterveld WJ
Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
[TBL] [Abstract][Full Text] [Related]
9. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
[No Abstract] [Full Text] [Related]
10. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
Tariska P; Paksy A
Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
[No Abstract] [Full Text] [Related]
12. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
[TBL] [Abstract][Full Text] [Related]
13. Piracetam and dyslexia: effects on reading tests.
Wilsher CR; Bennett D; Chase CH; Conners CK; DiIanni M; Feagans L; Hanvik LJ; Helfgott E; Koplewicz H; Overby P
J Clin Psychopharmacol; 1987 Aug; 7(4):230-7. PubMed ID: 3305591
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease.
Ondo WG; Tintner R; Voung KD; Lai D; Ringholz G
Mov Disord; 2005 Aug; 20(8):958-63. PubMed ID: 15800937
[TBL] [Abstract][Full Text] [Related]
15. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
Herrmann WM; Kern U
Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
[No Abstract] [Full Text] [Related]
16. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
[TBL] [Abstract][Full Text] [Related]
17. [Experience using nootropil in patients with chronic ischemic heart disease].
Shubina TI; Zaĭtsev VP
Klin Med (Mosk); 1989 May; 67(5):36-8. PubMed ID: 2671485
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
19. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
20. Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.
Oepen G; Eisele K; Thoden U; Birg W
Pharmacopsychiatry; 1985 Nov; 18(6):343-6. PubMed ID: 4089014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
